Literature DB >> 8272774

Treatment of large congenital naevi. A review and report of six cases.

M Sandsmark1, G Eskeland, A R Ogaard, F Abyholm, O P Clausen.   

Abstract

To minimize the significant risk of early malignancy, and to obtain acceptable cosmetic results we have treated five infants with large congenital naevi by full-thickness resection of the thickest part and superficial excision of the remaining parts of the naevus. The treatment was followed by rapid healing with little pigmented skin and minimal scarring. One patient treated at the age of six years showed a less favourable cosmetic result. Our experience confirms that the major part of the potentially malignant tissue can be removed and a greatly improved appearance achieved by early surgery. Additional surgery is usually necessary and should be completed before school age to prevent permanent psychological and social effects. Large congenital naevi are rare and difficult to treat. Their treatment should be centralised to regional hospitals that serve large populations.

Entities:  

Mesh:

Year:  1993        PMID: 8272774     DOI: 10.3109/02844319309078115

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  3 in total

1.  Combination laser therapy as a non-surgical method for treating congenital melanocytic nevi from cosmetically sensitive locations on the body.

Authors:  Emi Funayama; Yuhei Yamamoto; Akihiko Oyama; Naoki Murao; Toshihiko Hayashi; Taku Maeda; Hiroshi Furukawa; Masayuki Osawa
Journal:  Lasers Med Sci       Date:  2019-02-28       Impact factor: 3.161

2.  A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma.

Authors:  Ana Carolina Leite Viana; Eugênio Marcos Andrade Goulart; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

Review 3.  Giant congenital melanocytic nevus.

Authors:  Ana Carolina Leite Viana; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.